TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+1.3%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.45B
AUM Growth
-$11.8M
(-0.48%)
Cap. Flow
-$7.06M
Cap. Flow
% of AUM
-0.29%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
207
New
13
Increased
45
Reduced
58
Closed
10
Top Buys
| 1 |
Vertex Pharmaceuticals
VRTX
|
$8.44M |
| 2 |
Intuitive Surgical
ISRG
|
$8.07M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$7.96M |
| 4 |
Boston Scientific
BSX
|
$6.82M |
| 5 |
Gilead Sciences
GILD
|
$5.86M |
Top Sells
| 1 |
Biogen
BIIB
|
$21M |
| 2 |
Illumina
ILMN
|
$14.4M |
| 3 |
Elevance Health
ELV
|
$10.7M |
| 4 |
AGN
Allergan plc
AGN
|
$8.2M |
| 5 |
Welltower
WELL
|
$6.93M |
Sector Composition
| 1 | Healthcare | 95.11% |
| 2 | Real Estate | 2.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Masimo
MASI
$7.72B
| $4.13M | 0.17% |
27,732
+17,017
| +159% | +$2.53M |
|
102
argenx
ARGX
$45B
| $4.02M | 0.16% |
28,381
| – | – |
|
103
Amicus Therapeutics
FOLD
$2.44B
| $3.93M | 0.16% |
314,597
| – | – |
|
|
HZNP
104
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $3.79M | 0.15% |
157,473
+138,123
| +714% | +$3.32M |
|
105
Tenet Healthcare
THC
$16.9B
| $3.77M | 0.15% |
182,671
+41,535
| +29% | +$858K |
|
106
Philips
PHG
$26.3B
| $3.72M | 0.15% |
103,594
-2,489
| -2% | -$89.4K |
|
107
Sanofi
SNY
$111B
| $3.72M | 0.15% |
85,941
-93,959
| -52% | -$4.07M |
|
108
Merus
MRUS
$4.96B
| $3.59M | 0.15% |
245,114
-72,557
| -23% | -$1.06M |
|
|
GBT
109
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.55M | 0.14% |
67,516
-18,472
| -21% | -$972K |
|
110
Alcon
ALC
$38.9B
| $3.44M | 0.14% |
+55,369
| New | +$3.44M |
|
111
NovoCure
NVCR
$1.34B
| $3.42M | 0.14% |
54,074
-11,890
| -18% | -$752K |
|
|
ALBO
112
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $3.39M | 0.14% |
105,154
-19,846
| -16% | -$640K |
|
|
BCEL
113
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $3.3M | 0.13% |
+175,000
| New | +$3.3M |
|
114
LivaNova
LIVN
$3.14B
| $3.29M | 0.13% |
45,681
+34,281
| +301% | +$2.47M |
|
|
VAR
115
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.27M | 0.13% |
24,027
-2,200
| -8% | -$300K |
|
116
Medical Properties Trust
MPW
$2.66B
| $3.26M | 0.13% |
187,063
-139,000
| -43% | -$2.42M |
|
117
Takeda Pharmaceutical
TAK
$48.3B
| $3.15M | 0.13% |
178,128
| – | – |
|
|
PTLA
118
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.13M | 0.13% |
115,448
| – | – |
|
119
Xencor
XNCR
$608M
| $2.96M | 0.12% |
72,382
| – | – |
|
|
DHC
120
Diversified Healthcare Trust
DHC
$937M
| $2.96M | 0.12% |
357,720
| – | – |
|
121
Quest Diagnostics
DGX
$20.1B
| $2.65M | 0.11% |
26,012
-40,488
| -61% | -$4.12M |
|
122
IQVIA
IQV
$31.1B
| $2.64M | 0.11% |
16,391
| – | – |
|
123
Agilent Technologies
A
$36.2B
| $2.51M | 0.1% |
+33,600
| New | +$2.51M |
|
124
Intellia Therapeutics
NTLA
$1.25B
| $2.46M | 0.1% |
150,290
| – | – |
|
125
Ultragenyx Pharmaceutical
RARE
$3.02B
| $2.44M | 0.1% |
38,480
-38,478
| -50% | -$2.44M |
|